WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience MBF Bioscience Autoneuron
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, July 16, 2008, 28(29):7435-7444; doi:10.1523/JNEUROSCI.0727-08.2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Pernet, V.
Right arrow Articles by Schwab, M. E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pernet, V.
Right arrow Articles by Schwab, M. E.

 Previous Article  |  Next Article 

Development/Plasticity/Repair
Nogo-A and Myelin-Associated Glycoprotein Differently Regulate Oligodendrocyte Maturation and Myelin Formation

Vincent Pernet,1 Sandrine Joly,2 Franziska Christ,1 Leda Dimou,1 and Martin E. Schwab1

1Brain Research Institute, University of Zurich, and Department of Biology, Swiss Federal Institute of Technology, CH-8057 Zurich, Switzerland, and 2Laboratory for Retinal Cell Biology, Department of Ophthalmology, University of Zurich, CH-8091 Zurich, Switzerland

Correspondence should be addressed to Dr. Vincent Pernet, Brain Research Institute, University of Zurich/Swiss Federal Institute of Technology, Winterthurerstrasse 190, Room 55J34a, CH-8057 Zurich, Switzerland. Email: pernet{at}hifo.uzh.ch

Nogo-A is one of the most potent oligodendrocyte-derived inhibitors for axonal regrowth in the injured adult CNS. However, the physiological function of Nogo-A in development and in healthy oligodendrocytes is still unknown. In the present study, we investigated the role of Nogo-A for myelin formation in the developing optic nerve. By quantitative real-time PCR, we found that the expression of Nogo-A increased faster in differentiating oligodendrocytes than that of the major myelin proteins MBP (myelin basic protein), PLP (proteolipid protein)/DM20, and CNP (2',3'-cyclic nucleotide 3'-phosphodiesterase). The analysis of optic nerves and cerebella of mice deficient for Nogo-A (Nogo-A–/–) revealed a marked delay of oligodendrocyte differentiation, myelin sheath formation, and axonal caliber growth within the first postnatal month. The combined deletion of Nogo-A and MAG caused a more severe transient hypomyelination. In contrast to MAG–/– mice, Nogo-A–/– mutants did not present abnormalities in the structure of myelin sheaths and Ranvier nodes. The common binding protein for Nogo-A and MAG, NgR1, was exclusively upregulated in MAG–/– animals, whereas the level of Lingo-1, a coreceptor, remained unchanged. Together, our results demonstrate that Nogo-A and MAG are differently involved in oligodendrocyte maturation in vivo, and suggest that Nogo-A may influence also remyelination in pathological conditions such as multiple sclerosis.

Key words: Nogo-A; oligodendrocyte; myelination; OPC; optic nerve; cerebellum


Received Feb. 16, 2008; revised May 15, 2008; accepted June 9, 2008.

Correspondence should be addressed to Dr. Vincent Pernet, Brain Research Institute, University of Zurich/Swiss Federal Institute of Technology, Winterthurerstrasse 190, Room 55J34a, CH-8057 Zurich, Switzerland. Email: pernet{at}hifo.uzh.ch






-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-